In an era increasingly defined by complex, multifactorial diseases, such systems may be better suited to therapeutic intervention than narrowly targeted pathways optimized for reductionist endpoints
Under the negotiated terms, the government pays $245 per month for GLP-1 medications, a fraction of the $1,000-plus list price
There is currently no official indication or established evidence base for using GLP-1 medications specifically to treat vasomotor symptoms associated with menopause, and they should not be used off-label for this purpose
Armstrong JS, Whiteman M, Yang H, Jones DP, Sternberg Jr P
However, she called the osteoporosis finding an early signal, noting that I dont think its conclusive. Future research on GLP-1 medications should focus on the incidence of fractures, which bone density loss can increase risk of, she said